샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886127

세계의 인플루엔자 진단 시장

Influenza Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 171 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 인플루엔자 진단 시장은 2030년까지 49억 달러에 달할 전망

2024년에 36억 달러로 추정되는 세계의 인플루엔자 진단 시장은 2024년부터 2030년까지의 분석 기간 동안 CAGR 5.2%로 성장하여 2030년까지 49억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석 대상이 된 부문 중 하나인 RIDT(신속 진단 검사)는 6.1%의 CAGR을 기록하며 분석 기간 종료시까지 20억 달러에 달할 것으로 예측됩니다. RT-PCR 부문의 성장률은 분석 기간 동안 5.1%의 CAGR로 추정됩니다.

미국 시장은 9억 4,760만 달러로 추정되는 한편 중국은 8.0%의 CAGR로 성장할 것으로 예측됩니다

미국의 인플루엔자 진단 시장은 2024년에 9억 4,760만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년까지의 분석 기간 동안 CAGR 8.0%를 기록하며 2030년까지 11억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.7%와 4.9%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 3.1%의 CAGR로 성장할 것으로 예측됩니다.

세계의 인플루엔자 진단 시장 - 주요 시장 동향과 촉진요인 개요

독감 진단의 현재 기술이란?

독감 진단은 특히 계절적 유행이나 잠재적 유행병 관리에서 효과적인 의료 서비스 제공에 필수적인 요소로 자리 잡았습니다. 현재 인플루엔자 진단 기술에는 신속 인플루엔자 진단 검사(RIDT), 역전사 중합효소 연쇄 반응(RT-PCR), 바이러스 배양 등이 있습니다. RIDT는 30분 이내에 결과를 얻을 수 있는 신속성이 장점이며, 빠른 임상적 판단을 가능하게 합니다. 그러나 RT-PCR은 높은 민감도와 특이성으로 다양한 인플루엔자 균주를 구별할 수 있어 인플루엔자 진단의 골드 스탠다드로 여겨지고 있습니다. 바이러스 배양은 결과가 나오기까지 시간이 오래 걸리기 때문에 보급률이 낮지만, 역학 연구와 백신 개발에서 중요한 도구로 활용되고 있습니다. 최근의 발전은 인플루엔자와 다른 호흡기 병원체를 동시에 검출할 수 있는 다중 검사의 통합으로 검사의 효율성과 포괄성을 향상시키고 있습니다.

환자의 요구는 독감 진단을 어떻게 변화시키고 있는가?

의료 소비자(환자)의 지식이 깊어짐에 따라 신속하고 정확하며 편리한 진단법에 대한 수요가 증가하고 있습니다. 이러한 변화는 기존의 검사실 환경이 아닌 다양한 장소(약국, 자택 등)에서 시행할 수 있는 POC(Point-of-Care) 검사 개발을 촉진하고 있습니다. 이 검사는 사용자 친화적으로 설계되었으며, 최소한의 기술력으로 빠른 결과를 제공하여 대기 시간을 줄이고 적절한 치료 시작을 가속화합니다. 이러한 환자 중심의 접근 방식은 개인의 건강 상태를 개선할 뿐만 아니라 지역사회 내 바이러스 확산을 억제하는 데에도 기여하며, 독감 진단에 있어 접근성과 신속성의 중요성을 강조합니다.

기술은 독감 진단의 진화에 어떤 영향을 미치고 있는가?

기술 혁신은 독감 진단의 진화를 이끄는 주요 원동력입니다. 원격의료와 모바일 건강 앱을 포함한 디지털 헬스 기술의 부상은 독감 관리에 있어 매우 중요한 역할을 하고 있습니다. 이러한 기술은 원격 진단 및 모니터링을 가능하게 하며, 특히 독감 성수기나 유행병이 유행할 때 의료 시설에 큰 도움이 될 수 있습니다. 또한, 유전자 염기서열 분석과 생물정보학의 발전으로 효과적인 치료 및 백신 전략에 필수적인 균주 식별정확도와 속도가 향상되었습니다. 독감 초기 증상을 감지할 수 있는 바이오센서 및 웨어러블 디바이스의 개발도 유망한 분야로 발전하고 있어 조기 발견 및 개입이 가능해질 전망입니다.

독감 진단 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다...

독감 진단 시장의 성장은 전 세계적으로 계절성 독감 발생률 증가와 팬데믹 위협에 대한 인식 증가 등 여러 요인에 의해 촉진되고 있습니다. 급속한 도시화와 국제적인 이동으로 인해 바이러스의 확산이 가속화되면서 전 세계적으로 강력한 진단 솔루션이 필요하게 되었습니다. 진단 기술, 특히 신속 검사와 유전자 분석의 발전은 독감 진단의 대응 시간과 정확도를 크게 향상시켰습니다. 감염병 대응을 위한 정부의 노력과 자금 지원도 진단 시장 확대에 힘을 보태고 있습니다. 또한, 인공지능(AI)과 머신러닝을 진단 프로세스에 통합하여 데이터 분석과 해석을 강화함으로써 보다 정확하고 예측 가능한 진단을 가능하게 합니다. 전 세계 의료 시스템이 예방 의료와 조기 개입을 우선시하는 가운데, 고급 및 신속한 독감 진단 솔루션에 대한 수요는 계속 증가하고 있으며, 이 분야의 지속적인 성장을 보장합니다.

부문:

검사 유형(RIDT, RT-PCR, 세포배양, 기타 검사 유형), 최종 용도(병원, POCT, 검사실)

조사 대상 기업 예시

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석 방식을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업별 SLM을 쿼리하는 일반적인 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 동영상 전사, 블로그, 검색 엔진 조사, 그리고 방대한 양의 기업 데이터, 제품/서비스 데이터, 시장 데이터 등이 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.12.18

Global Influenza Diagnostics Market to Reach US$4.9 Billion by 2030

The global market for Influenza Diagnostics estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. RIDT, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the RT-PCR segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$947.6 Million While China is Forecast to Grow at 8.0% CAGR

The Influenza Diagnostics market in the U.S. is estimated at US$947.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Influenza Diagnostics Market - Key Trends & Drivers Summarized

What Are the Current Technologies in Influenza Diagnostics?

Influenza diagnostics have become critical for effective healthcare delivery, especially in managing seasonal outbreaks and potential pandemics. Current technologies in influenza diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR), and viral cultures. RIDTs offer the advantage of speed, providing results in less than 30 minutes, which facilitates swift clinical decisions. However, RT-PCR is the gold standard for influenza diagnostics due to its high sensitivity and specificity, capable of distinguishing between different influenza strains. Viral culture, while less common due to its longer turnaround time, remains an important tool for epidemiological studies and vaccine development. Recent advancements also include the integration of multiplex assays that can detect influenza alongside other respiratory pathogens, enhancing the efficiency and comprehensiveness of testing.

How Are Patient Demands Transforming Influenza Diagnostics?

As healthcare consumers become more informed, there is a growing demand for quicker, more accurate diagnostic methods that can be accessed conveniently. This shift is driving the development of point-of-care (POC) tests that can be administered in various settings outside the traditional laboratory environment, such as pharmacies or at home. These tests are designed to be user-friendly, requiring minimal technical skills and providing rapid results to reduce the waiting period and accelerate the initiation of appropriate treatments. This patient-centric approach not only improves individual health outcomes but also aids in controlling the spread of the virus in community settings, highlighting the importance of accessibility and speed in influenza diagnostics.

What Impact Does Technology Have on the Evolution of Influenza Diagnostics?

Technological innovation is a key driver in the evolution of influenza diagnostics. The emergence of digital health technologies, including telehealth and mobile health apps, is playing a crucial role in the management of influenza. These technologies allow for remote diagnosis and monitoring, which is particularly beneficial during peak flu seasons or pandemics when healthcare facilities are overwhelmed. Additionally, advancements in genetic sequencing and bioinformatics have improved the accuracy and speed of strain identification, which is vital for effective treatment and vaccination strategies. The ongoing development of biosensors and wearable devices that can detect early symptoms of influenza represents another promising frontier, potentially enabling even earlier detection and intervention.

Growth in the Influenza Diagnostics Market Is Driven by Several Factors…

The growth in the influenza diagnostics market is driven by several factors, including the increased global incidence of seasonal influenza and heightened awareness of pandemic threats. Rapid urbanization and international travel contribute to the faster spread of the virus, necessitating robust diagnostic solutions globally. Advances in diagnostic technologies, particularly in rapid testing and genetic analysis, have significantly improved the response time and accuracy of influenza diagnostics. Government initiatives and funding for infectious disease control further support the expansion of the diagnostics market. Additionally, the integration of artificial intelligence and machine learning in diagnostic processes enhances data analysis and interpretation, leading to more precise and predictive diagnostics. As healthcare systems worldwide prioritize preventive care and early intervention, the demand for advanced, rapid influenza diagnostic solutions continues to rise, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Influenza Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (RIDT, RT-PCR, Cell Culture, Other Test Types); End-Use (Hospitals, POCT, Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Influenza Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Seasonal and Pandemic Influenza Spurs Demand for Rapid Diagnostic Solutions
    • Advancements in Molecular Diagnostic Technologies Propel Growth in Influenza Testing
    • Increasing Focus on Early Detection and Prevention Expands Addressable Market for Influenza Diagnostics
    • Growing Adoption of Point-of-Care Testing Drives Demand for Rapid Influenza Diagnostic Kits
    • Stringent Regulatory Approvals and Guidelines Strengthen Business Case for High-Accuracy Diagnostic Solutions
    • Rising Awareness of Flu Vaccination Correlates with Increased Demand for Diagnostic Testing
    • Innovation in Multiplex Assays Generates Opportunities for Comprehensive Respiratory Disease Screening
    • AI and Machine Learning Enhance Diagnostic Accuracy and Predictive Analytics in Influenza Testing
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Demand for At-Home Influenza Testing Kits
    • Increasing Healthcare Investments in Emerging Markets Propel Growth in Influenza Diagnostics
    • Rising Demand for Digital Health Platforms Drives Adoption of Connected Diagnostic Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for RIDT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for POCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Influenza Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제